Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: a pilot study

FEBS Lett. 2005 May 23;579(13):2759-66. doi: 10.1016/j.febslet.2005.03.094. Epub 2005 Apr 19.

Abstract

Markers of oxidative stress in peripheral blood from patients with Alzheimer disease (AD) were analyzed. Thirty-three AD patients were recruited. Plasma antioxidant power (AOP), plasma Cystatin C as well as Cathepsin D in PBL were evaluated. We found that the AOP levels were significantly decreased in AD patients if compared to healthy donors, while the plasma level of Cystatin C was significantly higher. Importantly, a significantly decreased expression of Cathepsin D in PBL was also observed. These results suggest that oxidative imbalance in the peripheral blood of AD patients could mirror oxidative changes previously described in the central nervous system.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / blood*
  • Amyloid beta-Protein Precursor / blood
  • Biomarkers / blood*
  • Blood Platelets / metabolism
  • Cathepsin D / blood*
  • Cystatin C
  • Cystatins / blood
  • Female
  • Humans
  • Lymphocytes / metabolism
  • Male
  • Oxidative Stress*
  • Pilot Projects

Substances

  • Amyloid beta-Protein Precursor
  • Biomarkers
  • CST3 protein, human
  • Cystatin C
  • Cystatins
  • Cathepsin D